105 related articles for article (PubMed ID: 21879447)
1. HDACs in skeletal muscle remodeling and neuromuscular disease.
Simmons BJ; Cohen TJ; Bedlack R; Yao TP
Handb Exp Pharmacol; 2011; 206():79-101. PubMed ID: 21879447
[TBL] [Abstract][Full Text] [Related]
2. The biology and therapeutic implications of HDACs in the heart.
McKinsey TA
Handb Exp Pharmacol; 2011; 206():57-78. PubMed ID: 21879446
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylases--an important class of cellular regulators with a variety of functions.
Hildmann C; Riester D; Schwienhorst A
Appl Microbiol Biotechnol; 2007 Jun; 75(3):487-97. PubMed ID: 17377789
[TBL] [Abstract][Full Text] [Related]
4. Protein deacetylases: enzymes with functional diversity as novel therapeutic targets.
Yoshida M; Shimazu T; Matsuyama A
Prog Cell Cycle Res; 2003; 5():269-78. PubMed ID: 14593721
[TBL] [Abstract][Full Text] [Related]
5. Acetylation of proteins as novel target for antitumor therapy: review article.
Di Gennaro E; Bruzzese F; Caraglia M; Abruzzese A; Budillon A
Amino Acids; 2004 Jul; 26(4):435-41. PubMed ID: 15290351
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors: keeping momentum for neuromuscular and cardiovascular diseases treatment.
Colussi C; Illi B; Rosati J; Spallotta F; Farsetti A; Grasselli A; Mai A; Capogrossi MC; Gaetano C
Pharmacol Res; 2010 Jul; 62(1):3-10. PubMed ID: 20227503
[TBL] [Abstract][Full Text] [Related]
7. Histone modifications and skeletal muscle metabolic gene expression.
McGee SL; Hargreaves M
Clin Exp Pharmacol Physiol; 2010 Mar; 37(3):392-6. PubMed ID: 19793100
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase 9 couples neuronal activity to muscle chromatin acetylation and gene expression.
Méjat A; Ramond F; Bassel-Duby R; Khochbin S; Olson EN; Schaeffer L
Nat Neurosci; 2005 Mar; 8(3):313-21. PubMed ID: 15711539
[TBL] [Abstract][Full Text] [Related]
9. Proteomics of skeletal muscle differentiation, neuromuscular disorders and fiber aging.
Ohlendieck K
Expert Rev Proteomics; 2010 Apr; 7(2):283-96. PubMed ID: 20377394
[TBL] [Abstract][Full Text] [Related]
10. The discovery of histone deacetylase.
Yao TP; Seto E
Handb Exp Pharmacol; 2011; 206():v. PubMed ID: 22046630
[No Abstract] [Full Text] [Related]
11. Protein acetylation in the cardiorenal axis: the promise of histone deacetylase inhibitors.
Bush EW; McKinsey TA
Circ Res; 2010 Feb; 106(2):272-84. PubMed ID: 20133912
[TBL] [Abstract][Full Text] [Related]
12. Pattern of metalloprotease activity and myofiber regeneration in skeletal muscles of mdx mice.
Bani C; Lagrota-Candido J; Pinheiro DF; Leite PE; Salimena MC; Henriques-Pons A; Quirico-Santos T
Muscle Nerve; 2008 May; 37(5):583-92. PubMed ID: 18288709
[TBL] [Abstract][Full Text] [Related]
13. HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention.
Yang XJ; Seto E
Oncogene; 2007 Aug; 26(37):5310-8. PubMed ID: 17694074
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase activity is required for the induction of the MyoD muscle cell lineage in Xenopus.
Steinbac OC; Wolffe AP; Rupp RA
Biol Chem; 2000; 381(9-10):1013-6. PubMed ID: 11076034
[TBL] [Abstract][Full Text] [Related]
15. Structural biology of human metal-dependent histone deacetylases.
Schapira M
Handb Exp Pharmacol; 2011; 206():225-40. PubMed ID: 21879452
[TBL] [Abstract][Full Text] [Related]
16. Chromatin acetylation status in the manifestation of neurodegenerative diseases: HDAC inhibitors as therapeutic tools.
Anne-Laurence B; Caroline R; Irina P; Jean-Philippe L
Subcell Biochem; 2007; 41():263-93. PubMed ID: 17484132
[TBL] [Abstract][Full Text] [Related]
17. Targeting the correct HDAC(s) to treat cognitive disorders.
Fischer A; Sananbenesi F; Mungenast A; Tsai LH
Trends Pharmacol Sci; 2010 Dec; 31(12):605-17. PubMed ID: 20980063
[TBL] [Abstract][Full Text] [Related]
18. Transcription regulation by histone deacetylases.
Wang S; Yan-Neale Y; Zeremski M; Cohen D
Novartis Found Symp; 2004; 259():238-45; discussion 245-8, 285-8. PubMed ID: 15171258
[TBL] [Abstract][Full Text] [Related]
19. Influence of AMP-activated protein kinase and calcineurin on metabolic networks in skeletal muscle.
Long YC; Zierath JR
Am J Physiol Endocrinol Metab; 2008 Sep; 295(3):E545-52. PubMed ID: 18544643
[TBL] [Abstract][Full Text] [Related]
20. Skeletal muscle remodeling.
Potthoff MJ; Olson EN; Bassel-Duby R
Curr Opin Rheumatol; 2007 Nov; 19(6):542-9. PubMed ID: 17917533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
